Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Fatty acid amide hydrolase (FAAH) inhibitors exert pharmacological effects, but lack antinociceptive efficacy in rats with neuropathic spinal cord injury pain

Academic Article
uri icon
  • Overview
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Hama, A. T.
  • Germano, P.
  • Varghese, M. S.
  • Cravatt, Benjamin
  • Milne, G. T.
  • Pearson, J. P.
  • Sagen, J.

publication date

  • May 2014

journal

  • PLoS One  Journal

abstract

  • Amelioration of neuropathic spinal cord injury (SCI) pain is a clinical challenge. Increasing the endocannabinoid anandamide and other fatty acid amides (FAA) by blocking fatty acid amide hydrolase (FAAH) has been shown to be antinociceptive in a number of animal models of chronic pain. However, an antinociceptive effect of blocking FAAH has yet to be demonstrated in a rat model of neuropathic SCI pain. Four weeks following a SCI, rats developed significantly decreased hind paw withdrawal thresholds, indicative of below-level cutaneous hypersensitivity. A group of SCI rats were systemically treated (i.p.) with either the selective FAAH inhibitor URB597 or vehicle twice daily for seven days. A separate group of SCI rats received a single dose (p.o.) of either the selective FAAH inhibitor PF-3845 or vehicle. Following behavioral testing, levels of the FAA N-arachidonoylethanolamide, N-oleoyl ethanolamide and N-palmitoyl ethanolamide were quantified in brain and spinal cord from SCI rats. Four weeks following SCI, FAA levels were markedly reduced in spinal cord tissue. Although systemic treatment with URB597 significantly increased CNS FAA levels, no antinociceptive effect was observed. A significant elevation of CNS FAA levels was also observed following oral PF-3845 treatment, but only a modest antinociceptive effect was observed. Increasing CNS FAA levels alone does not lead to robust amelioration of below-level neuropathic SCI pain. Perhaps utilizing FAAH inhibition in conjunction with other analgesic mechanisms could be an effective analgesic therapy.

subject areas

  • Amidohydrolases
  • Analgesics
  • Animals
  • Arachidonic Acids
  • Benzamides
  • Benzoxazines
  • Brain
  • Carbamates
  • Endocannabinoids
  • Enzyme Inhibitors
  • Hindlimb
  • Male
  • Morpholines
  • Naphthalenes
  • Neuralgia
  • Pain Measurement
  • Pain Threshold
  • Piperidines
  • Polyunsaturated Alkamides
  • Pyridines
  • Rats, Sprague-Dawley
  • Spinal Cord
  • Spinal Cord Injuries
  • Treatment Outcome
scroll to property group menus

Identity

PubMed Central ID

  • PMC4008577

International Standard Serial Number (ISSN)

  • 1932-6203

Digital Object Identifier (DOI)

  • 10.1371/journal.pone.0096396

PubMed ID

  • 24788435
scroll to property group menus

Additional Document Info

start page

  • e96396

volume

  • 9

issue

  • 5

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support